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Identity 
Other names: Louis-Bar syndrome 
Inheritance: Autosomal recessive; frequency is about 
1 to 2.5/105 newborns; as there are complementation 
groups, heterozygotes may be as frequent as 2% of the 
general population; a founder effect is found in some 
areas. 
Clinics 
Ataxia telangiectasia is a chromosome instability 
syndrome with cerebellar degeneration, 
immunodeficiency, and an increased risk of cancers. 
Phenotype and clinics 
- Onset of the disease is often during the second year of 
life: there is progressive cerebellar ataxia (initially 
truncal, with further peripheral extend); ataxia is a 
constant feature in this disease; oculomotor apraxia, 
dysarthria, and dystonia; leading to muscular atrophia. 
- Telangiectasia: facial region exposed to sunlight, and 
eyes (conjunctiva). 
- Combined immunodeficiency (in 70 %): thymus 
hypoplasia, and IgG2 and 4, IgA, IgE deficiency. 
- Other features: growth retardation; hypogonadism; 
diabetes mellitus. 
- Mental retardation may occur. 
Neoplastic risk 
Risk of cancers is X 100: 
- Mainly T-cell malignancies (a 70 fold and 250 fold 
increased risks of leukaemia and lymphoma 
respectively), 
- But also: carcinomas of the skin, the ovary, the breast, 
the stomach...; B-cell malignancies; but no myeloid 
leukaemia. 
Evolution 
Progressive cerebellar degeneration: patients are in a 
wheelchair by the age of ten. 
Prognosis 
Respiratory infections are the common cause of death 
(80%), and cancers are responsible for the remaining 




- Spontaneous chromatid/chromosome breaks, 
triradials, quadriradials (less prominent phenomenon 
than in Fanconi anaemia); telomeric associations. 
- The best diagnosis test is on the (pathognomonic) 
highly elevated level (10% of mitoses) of 
inv(7)(p14q35), t(14;14)(q11;q32), and other non 
clonal stable chromosome rearrangements involving 
2p12, 7p14, 7q35, 14q11, 14q32, and 22q11 
(illegitimate recombinations between immunoglobulin 
superfamilly genes Ig and TCR); normal level of those 
rearrangements are: 1/500 (inv(14)), 1/200 (t(7;14)), 
1/10 000 (inv(7)). 
- Clonal rearrangements further occur in 10% of 
patients, but without manifestation of malignancy: 
t(14;14), inv(14), or t(X;14). 
Cancer cytogenetics 
Clonal rearrangements in T-cell ALL and T-PLL 
(prolymphocytic leukaemia) in AT patients are 
complex, with the frequent involvement of t(14;14), or 
t(X;14), implicating the genes TCL1 or MTCP1 
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Other findings 
Note:  
- High sensitivity to radiations and to radiomimetic 
drugs (diagnostic may in part be based on the 
hypersensitivity of AT lymphocytes to killing by 
gamma irradiation); cell irradiation does not inhibit S 
phase (DNA synthesis): this is quite pathognomonic of 
AT, and shows that G1 checkpoint is deficient; there is 
a lack of P53, GADD45 and P21 induction, and a fall 
in radiation-induced apoptosis. 
- Lenthening of the cell cycle. 
- Difficulty to grow cells with phytohemaglutinin: 
karyotypes should be performed with interleukine 2 in 
4 days cultures. 
- Other: increased level of serum alpha-fetoprotein. 
Genes involved and Proteins 
Complementation groups : 
4 complementation groups: A, C, D, and E; although 
there is only 1 gene involved in this disease. 
ATM 
Location: 11q22 
DNA / RNA 
Description: 66 exons. 
Protein 
Description: contains a Pl 3-kinase-like domain. 
Localisation: mostly in the nucleus. 
Function: in the cell cycle regulation (G1/S and S 
phase): mediating cell cycle arrest in response to 
radiations. 
Mutations 
Germinal: various types of mutations, dispersed 
throughout the gene, and therefore most patients are 
compound heterozygotes; however, most mutations 
appear to inactivate the ATM protein by truncation, 
large deletions, or annulation of initiation or 
termination. 
To be noted 
- As ataxia telangiectasia patients have a high 
sensitivity to radiation, they cannot tolerate the 
therapeutic radiation usually given to cancer patients. 
- Heterozygous for AT may be at increased (up to X 7) 
risk of breast cancer; i.e. 10 to 20% of patients with 
breast cancer could be heterozygous for AT (Swift et 
al. 1991), and may also have a X 3 risk for other 
cancers. 
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